MedTrace Logo

Exparel as a Nerve Block for Severe Hand Pain

NCT02374320 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2024-05-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate whether the use of the study drug (Exparel) is safe and effective for treating circulation problems and pain in the hand or fingers.

Conditions

  • CREST Syndrome
  • Peripheral Vascular Disease
  • Raynaud Disease
  • Scleroderma, Diffuse

Interventions

DRUG

liposomal bupivacaine

injected as an axillary block

Sponsors & Collaborators

  • Jose Soberon, MD

    lead OTHER

Principal Investigators

  • Jose Soberon, MD · Ochsner Health System

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02374320 on ClinicalTrials.gov